erythrosine has been researched along with Encephalitis in 18 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Encephalitis: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with diapocynin also significantly improved locomotor activity, restored dopamine and its metabolites, and protected dopaminergic neurons and their nerve terminals in this pre-clinical model of PD." | 1.38 | Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. ( Anantharam, V; Dranka, BP; Ghosh, A; Joseph, J; Kalyanaraman, B; Kanthasamy, A; Kanthasamy, AG; Srivastava, P, 2012) |
| "Atorvastatin treatment was neuroprotective against cell degeneration induced by Aβ(1-40), reducing inflammatory and oxidative responses and increasing the expression of glutamatergic transporters." | 1.36 | Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. ( Bezerra, SC; de Bem, AF; Duarte, FS; Figueiredo, CP; Mancini, G; Piermartiri, TC; Prediger, RD; Rial, D; Tasca, CI, 2010) |
| " The animals were treated with either one of the drugs at previously defined relevant dosage or control." | 1.33 | Neuronal degeneration and iNOS expression in experimental brain contusion following treatment with colchicine, dexamethasone, tirilazad mesylate and nimodipine. ( Gahm, C; Holmin, S; Mathiesen, T; Rudehill, S, 2005) |
| "Rats were subjected to permanent embolic middle cerebral artery occlusion (MCAO) and allowed to recover before receiving subcutaneous injections of 15 mg/kg of DTG at 24, 48, and 72 hours." | 1.33 | Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. ( Ajmo, CT; Collier, L; Cuevas, J; Pennypacker, KR; Vernon, DO, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R | 1 |
| Liu, W | 1 |
| Yin, J | 1 |
| Chen, Y | 1 |
| Guo, S | 1 |
| Fan, H | 1 |
| Li, X | 1 |
| Zhang, X | 1 |
| He, X | 1 |
| Duan, C | 1 |
| Kuwar, R | 1 |
| Rolfe, A | 1 |
| Di, L | 1 |
| Xu, H | 1 |
| He, L | 1 |
| Jiang, Y | 1 |
| Zhang, S | 1 |
| Sun, D | 1 |
| Briones, TL | 1 |
| Woods, J | 1 |
| Wadowska, M | 1 |
| Yang, L | 1 |
| Tang, J | 1 |
| Chen, Q | 1 |
| Jiang, B | 1 |
| Zhang, B | 1 |
| Tao, Y | 1 |
| Li, L | 1 |
| Chen, Z | 1 |
| Zhu, G | 1 |
| Ahmad, A | 1 |
| Shah, SA | 1 |
| Badshah, H | 1 |
| Kim, MJ | 1 |
| Ali, T | 1 |
| Yoon, GH | 1 |
| Kim, TH | 1 |
| Abid, NB | 1 |
| Rehman, SU | 1 |
| Khan, S | 1 |
| Kim, MO | 1 |
| Ophelders, DR | 1 |
| Gussenhoven, R | 1 |
| Lammens, M | 1 |
| Küsters, B | 1 |
| Kemp, MW | 1 |
| Newnham, JP | 1 |
| Payne, MS | 1 |
| Kallapur, SG | 1 |
| Jobe, AH | 1 |
| Zimmermann, LJ | 1 |
| Kramer, BW | 1 |
| Wolfs, TG | 1 |
| Wang, J | 1 |
| Doré, S | 1 |
| Antonini, JM | 1 |
| Sriram, K | 1 |
| Benkovic, SA | 1 |
| Roberts, JR | 1 |
| Stone, S | 1 |
| Chen, BT | 1 |
| Schwegler-Berry, D | 1 |
| Jefferson, AM | 1 |
| Billig, BK | 1 |
| Felton, CM | 1 |
| Hammer, MA | 1 |
| Ma, F | 1 |
| Frazer, DG | 1 |
| O'Callaghan, JP | 1 |
| Miller, DB | 1 |
| Piermartiri, TC | 1 |
| Figueiredo, CP | 1 |
| Rial, D | 1 |
| Duarte, FS | 1 |
| Bezerra, SC | 1 |
| Mancini, G | 1 |
| de Bem, AF | 1 |
| Prediger, RD | 1 |
| Tasca, CI | 1 |
| Serrano, GE | 1 |
| Lelutiu, N | 1 |
| Rojas, A | 1 |
| Cochi, S | 1 |
| Shaw, R | 1 |
| Makinson, CD | 1 |
| Wang, D | 1 |
| FitzGerald, GA | 1 |
| Dingledine, R | 1 |
| Ghosh, A | 1 |
| Kanthasamy, A | 1 |
| Joseph, J | 1 |
| Anantharam, V | 1 |
| Srivastava, P | 1 |
| Dranka, BP | 1 |
| Kalyanaraman, B | 1 |
| Kanthasamy, AG | 1 |
| Gahm, C | 1 |
| Holmin, S | 1 |
| Rudehill, S | 1 |
| Mathiesen, T | 1 |
| Ajmo, CT | 1 |
| Vernon, DO | 1 |
| Collier, L | 1 |
| Pennypacker, KR | 1 |
| Cuevas, J | 1 |
| Shirakawa, T | 1 |
| Nakano, K | 1 |
| Hachiya, NS | 1 |
| Kato, N | 1 |
| Kaneko, K | 1 |
| Veiga, S | 1 |
| Carrero, P | 1 |
| Pernia, O | 1 |
| Azcoitia, I | 1 |
| Garcia-Segura, LM | 1 |
| Yang, MS | 1 |
| Park, EJ | 1 |
| Sohn, S | 1 |
| Kwon, HJ | 1 |
| Shin, WH | 1 |
| Pyo, HK | 1 |
| Jin, B | 1 |
| Choi, KS | 1 |
| Jou, I | 1 |
| Joe, EH | 1 |
| Chan, SP | 1 |
| Kurtz, JB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Early Atorvastatin Treatment During the Acute Phase of Stroke on Immunoinflammatory Markers and Outcome in Patients With Acute Ischemic Stroke Classified as LAAS According TOAST Classification[NCT02225834] | Phase 4 | 50 participants (Actual) | Interventional | 2011-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 other studies available for erythrosine and Encephalitis
| Article | Year |
|---|---|
TSG-6 attenuates inflammation-induced brain injury via modulation of microglial polarization in SAH rats through the SOCS3/STAT3 pathway.
Topics: Animals; Anti-Inflammatory Agents; Brain Edema; Cell Adhesion Molecules; Cell Polarity; Cytokines; D | 2018 |
A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury.
Topics: Analysis of Variance; Animals; Brain Injuries, Traumatic; CD11b Antigen; Disease Models, Animal; Dos | 2019 |
Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling.
Topics: Animals; CD11b Antigen; Chemokine CX3CL1; Cognition Disorders; CX3C Chemokine Receptor 1; Discrimina | 2014 |
Hyperbaric oxygen preconditioning attenuates neuroinflammation after intracerebral hemorrhage in rats by regulating microglia characteristics.
Topics: Analysis of Variance; Animals; Brain Edema; Calcium-Binding Proteins; CD11b Antigen; Cell Count; Cer | 2015 |
Neuroprotection by Vitamin C Against Ethanol-Induced Neuroinflammation Associated Neurodegeneration in the Developing Rat Brain.
Topics: Animals; Animals, Newborn; Apoptosis; Ascorbic Acid; bcl-2-Associated X Protein; Brain; Caspase 3; C | 2016 |
Neuroinflammation and structural injury of the fetal ovine brain following intra-amniotic Candida albicans exposure.
Topics: Animals; Brain Injuries; Calcium-Binding Proteins; Candida albicans; Candidiasis; Caspase 3; Disease | 2016 |
Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage.
Topics: Analysis of Variance; Animals; Brain Edema; Calcium-Binding Proteins; Cerebral Hemorrhage; Cytochrom | 2008 |
Mild steel welding fume causes manganese accumulation and subtle neuroinflammatory changes but not overt neuronal damage in discrete brain regions of rats after short-term inhalation exposure.
Topics: Animals; Brain; Catecholamines; Cation Transport Proteins; Chromatography, High Pressure Liquid; Cyt | 2009 |
Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage.
Topics: Amino Acid Transport System X-AG; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, New | 2010 |
Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.
Topics: Alprostadil; Animals; Blood-Testis Barrier; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Ele | 2011 |
Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Chromatography, High Pressure | 2012 |
Neuronal degeneration and iNOS expression in experimental brain contusion following treatment with colchicine, dexamethasone, tirilazad mesylate and nimodipine.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Brain; Brain Injuries; Calcium Channel Blockers; Cell | 2005 |
Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats.
Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Biomarkers; Brain; Brain Ischemia; Cell Survival | 2006 |
Temporospatial patterns of COX-2 expression and pyramidal cell degeneration in the rat hippocampus after trimethyltin administration.
Topics: Animals; Cell Survival; Corticosterone; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Encephalitis; | 2007 |
Translocator protein 18 kDa is involved in the regulation of reactive gliosis.
Topics: Animals; Antineoplastic Agents; Astrocytes; Benzodiazepinones; Biomarkers; Cell Death; Cell Prolifer | 2007 |
Interleukin-13 and -4 induce death of activated microglia.
Topics: Animals; Animals, Newborn; Brain Injuries; Cell Death; Cell Size; Cells, Cultured; Encephalitis; Eth | 2002 |
Induction of chronic measles encephalitis in C57BL/6 mice.
Topics: Aging; Animals; Brain; Encephalitis; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibod | 1985 |
Specific IgG and IgM antibody responses in herpes-simplex-virus infections.
Topics: Adolescent; Adult; Aged; Animals; Antibody Formation; Cells, Cultured; Centrifugation, Density Gradi | 1974 |